ACHV - CIK 0000949858
The table below shows ACHIEVE LIFE SCIENCES, INC.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$49.47M | -$29.77M | -$24.48M | -$37.57M | -$29.44M | -$13.47M |
| Capital expenditure | $3.00K | - | $21.00K | - | - | $17.00K |
| Investing cash flow | $6.11M | -$21.58M | -$21.00K | - | - | -$17.00K |
| Dividends paid | - | - | - | - | - |
ACHIEVE LIFE SCIENCES, INC. reported operating cash flow of -$49.47M for fiscal year 2025. That is down 66.2% from -$29.77M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$202.00K (FY 2016) to -$49.47M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $51.53M | $48.53M | $15.28M | $19.32M | $36.61M | $32.68M |